KATARZYNA TESZ: Open Payments
NPI 1205593209 · BERLIN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 50 payments from 12 companies in 2025. Trend: 2023 $1,021 · 2024 $778 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $242 |
| Axsome Therapeutics, Inc. | 6 | $106 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $67 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Almatica Pharma LLC | 2 | $34 |
| Alkermes, Inc. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Corium, LLC | 1 | $24 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
Products named: VRAYLAR, Auvelity, CAPLYTA, SPRAVATO, REXULTI, LOREEV XR, ARISTADA, COBENFY.
Industry payments across CT — which companies pay providers there.
